We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




PSMA PET Imaging Set to Become New Standard of Care for Detecting Prostate Cancer Metastases

By MedImaging International staff writers
Posted on 18 Feb 2022
Print article
Image: PSMA-Targeted Therapy in Prostate Cancer (Photo courtesy of Pexels)
Image: PSMA-Targeted Therapy in Prostate Cancer (Photo courtesy of Pexels)

PSMA PET imaging will soon become the new standard of care for detecting prostate cancer metastases, leading to improved care for these patients.

These are the latest findings of the Cleveland Clinic (Cleveland, OH, USA) which has ranked PSMA PET imaging at No. 2 on its list of the top 10 medical innovations to watch in 2022.

With a one in eight chance of diagnosis, prostate cancer is an ever-present worry for men. While many patients survive the disease, some develop metastatic cancer, which can lead to a poor outcome and possibly death. Early detection and imaging using CT and MRI scans are critical for staging and tumor location, but offer limited accuracy. Now, a promising new imaging technology has emerged, called prostate-specific membrane antigen positron emission tomography, or PSMA PET.

PSMA is an antigen found in high levels on the surface of prostate cancer cells and is a potential biomarker for disease. PSMA PET uses a radioactive tracer to locate and attach to PSMA proteins, which are then visible by PET. This targeted approach can be used in conjunction with CT or MRI scans to visualize where prostate cancer cells are residing. Results during phase three clinical trials showed substantially increased accuracy for detection of prostate metastasis compared to conventional imaging. FDA approved in 2021, experts say the PET tracer procedure will soon become the new standard of care for detecting prostate cancer metastasis, leading to improved care for these patients.

Related Links:
Cleveland Clinic 

Gold Supplier
Conductive Gel
Tensive
Gold Supplier
128 Slice CT Scanner
Supria 128
New
Radiotherapy Software
Node Platform
New
Multi-Purpose C-Arm System
Celex

Print article
Sun Nuclear -    Mirion

Channels

Radiography

view channel
Image: Radiologists outperformed AI in identifying lung diseases on chest X-ray (Photo courtesy of RSNA)

Radiologists Beat AI in Detecting Common Lung Diseases on Chest X-Rays

Chest X-rays are frequently used for diagnosis, but it takes a lot of training and expertise to read these images correctly. Although the Food and Drug Administration (FDA) has approved some artificial... Read more

Ultrasound

view channel
Image: The new device targets ultrasound waves to precise spots in the brain (Photo courtesy of WUSTL)

Anatomically Precise Ultrasound-Based Technique to Enable Noninvasive Biopsies for Brain Tumors

The blood-brain barrier serves as a protective wall, keeping the brain safe from harmful elements like viruses and toxins in the blood. This makes it challenging for doctors to obtain molecular and genetic... Read more

Nuclear Medicine

view channel
Image: Imaging entire body instead of only the primary cancer site can provide a total estimate of HER2 expression (Photo courtesy of 123RF)

Whole-Body PET/CT Predicts Response to HER2-Targeted Therapy in Metastatic Breast Cancer Patients

Around 20% of women diagnosed with breast cancer show overexpression of human epidermal growth factor receptor 2 (HER2), making it a key therapy target for new as well as recurring cases.... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The partnership combines best-in-class AI-powered technologies for musculoskeletal imaging workflows (Photo courtesy of ImageBiopsy Lab)

AI-Powered Technologies to Aid Interpretation of X-Ray and MRI Images for Improved Disease Diagnosis

Musculoskeletal (MSK) conditions impact more people worldwide than issues related to the circulatory or respiratory systems. Even so, diagnostic procedures for these conditions often still lean on outdated... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.